AU2008285364A1 - Chlorotoxins as drug carriers - Google Patents

Chlorotoxins as drug carriers Download PDF

Info

Publication number
AU2008285364A1
AU2008285364A1 AU2008285364A AU2008285364A AU2008285364A1 AU 2008285364 A1 AU2008285364 A1 AU 2008285364A1 AU 2008285364 A AU2008285364 A AU 2008285364A AU 2008285364 A AU2008285364 A AU 2008285364A AU 2008285364 A1 AU2008285364 A1 AU 2008285364A1
Authority
AU
Australia
Prior art keywords
cancer
conjugate
agent
moiety
agents
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Abandoned
Application number
AU2008285364A
Other languages
English (en)
Inventor
Douglas Jacoby
Abdellah Sentissi
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Transmolecular Inc
Original Assignee
Transmolecular Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Transmolecular Inc filed Critical Transmolecular Inc
Publication of AU2008285364A1 publication Critical patent/AU2008285364A1/en
Abandoned legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/50—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates
    • A61K47/51—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent
    • A61K47/62—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent the modifying agent being a protein, peptide or polyamino acid
    • A61K47/64—Drug-peptide, drug-protein or drug-polyamino acid conjugates, i.e. the modifying agent being a peptide, protein or polyamino acid which is covalently bonded or complexed to a therapeutically active agent
    • A61K47/6415—Toxins or lectins, e.g. clostridial toxins or Pseudomonas exotoxins
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • General Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Chemical & Material Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Medicinal Chemistry (AREA)
  • Public Health (AREA)
  • Epidemiology (AREA)
  • Toxicology (AREA)
  • Molecular Biology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Medicinal Preparation (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
AU2008285364A 2007-08-07 2008-08-07 Chlorotoxins as drug carriers Abandoned AU2008285364A1 (en)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US95440907P 2007-08-07 2007-08-07
US60/954,409 2007-08-07
PCT/US2008/072524 WO2009021136A1 (en) 2007-08-07 2008-08-07 Chlorotoxins as drug carriers

Publications (1)

Publication Number Publication Date
AU2008285364A1 true AU2008285364A1 (en) 2009-02-12

Family

ID=40341745

Family Applications (1)

Application Number Title Priority Date Filing Date
AU2008285364A Abandoned AU2008285364A1 (en) 2007-08-07 2008-08-07 Chlorotoxins as drug carriers

Country Status (6)

Country Link
US (1) US20110091380A1 (https=)
EP (1) EP2173385A1 (https=)
JP (1) JP2010535811A (https=)
AU (1) AU2008285364A1 (https=)
CA (1) CA2696303A1 (https=)
WO (1) WO2009021136A1 (https=)

Families Citing this family (12)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
ATE502048T1 (de) 2005-04-22 2011-04-15 Univ Washington Fluoreszentes chlorotoxinkonjugat und verfahren zur intraoperativen sichtbarmachung von krebs
US8227439B2 (en) 2008-05-15 2012-07-24 Morphotek, Inc. Treatment of metastatic tumors
JP5858932B2 (ja) 2010-02-04 2016-02-10 モルフォテック， インコーポレイテッド クロロトキシンポリペプチドおよびコンジュゲートならびにその使用
JP5909611B2 (ja) * 2010-04-06 2016-04-27 愛知県 癌細胞選択的膜透過性ペプチドおよびその利用
JP2013532126A (ja) 2010-05-11 2013-08-15 フレッド ハッチンソン キャンサー リサーチ センター クロロトキシン変異体、コンジュゲート、およびそれらを使用する方法
WO2013003507A1 (en) 2011-06-27 2013-01-03 Morphotek, Inc. Multifunctional agents
CN105008393A (zh) 2012-12-10 2015-10-28 弗莱德哈钦森癌症研究中心 用于筛选的方法
US11559580B1 (en) 2013-09-17 2023-01-24 Blaze Bioscience, Inc. Tissue-homing peptide conjugates and methods of use thereof
WO2017181149A1 (en) 2016-04-15 2017-10-19 Blaze Bioscience, Inc. Methods of treating breast cancer
KR102618373B1 (ko) * 2016-12-09 2023-12-29 유에이비 리서치 파운데이션 키메라성 클로로톡신 수용체
EP3681540A4 (en) 2017-09-15 2021-05-19 Eisai, Inc. CHLOROTOXIN AGENT AND USES THEREOF
EP3727146A4 (en) 2017-12-19 2021-10-06 Blaze Bioscience, Inc. TUMOR HOMING AND CELL-PENETANT PEPTIDE IMMUNO-ONCOLOGY AGENT COMPLEX AND METHOD OF USE

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6667156B2 (en) * 1995-12-27 2003-12-23 Uab Research Foundation Diagnosis and treatment of neuroectodermal tumors
US5905027A (en) * 1995-12-27 1999-05-18 Uab Research Foundation Method of diagnosing and treating gliomas
WO2003101474A1 (en) * 2002-05-31 2003-12-11 Transmolecular, Inc. Combination chemotherapy with chlorotoxin
US20060088899A1 (en) * 2002-05-31 2006-04-27 Alvarez Vernon L Combination chemotherapy with chlorotoxin
JP2008507280A (ja) * 2004-07-21 2008-03-13 アンブレツクス・インコーポレイテツド 非天然コードアミノ酸を用いた生合成ポリペプチド
ATE502048T1 (de) * 2005-04-22 2011-04-15 Univ Washington Fluoreszentes chlorotoxinkonjugat und verfahren zur intraoperativen sichtbarmachung von krebs

Also Published As

Publication number Publication date
CA2696303A1 (en) 2009-02-12
WO2009021136A1 (en) 2009-02-12
US20110091380A1 (en) 2011-04-21
JP2010535811A (ja) 2010-11-25
EP2173385A1 (en) 2010-04-14

Similar Documents

Publication Publication Date Title
US10183975B2 (en) Chlorotoxin polypeptides and conjugates and uses thereof
US20110091380A1 (en) Chlorotoxins as drug carriers
US9603952B2 (en) Treatment of metastatic tumors
AU2008310664A1 (en) Systemic administration of chlorotoxin agents for the diagnosis and treatment of tumors
WO2013003507A1 (en) Multifunctional agents
WO2019055840A1 (en) CHLOROTOXIN AGENTS AND USES THEREOF
US20110152252A1 (en) Shiga toxin b-subunit/chemotherapeutics conjugates
AU2015201510B2 (en) Chlorotoxin polypeptides and conjugates and uses thereof
HK1240244B (zh) 氯毒素多肽和结合物及其应用
HK1240244A1 (en) Chlorotoxin polypeptides and conjugates and uses thereof

Legal Events

Date Code Title Description
MK1 Application lapsed section 142(2)(a) - no request for examination in relevant period